Editas Medicine gets approval for first-in-human trial of EDIT-401
Editas Medicine received approval to initiate first-in-human clinical trial of EDIT-401 in patients with hyperlipidemia.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Editas Medicine received approval to initiate first-in-human clinical trial of EDIT-401 in patients with hyperlipidemia.